Empresa Fennec Pharmaceuticals Inc. Nasdaq
Acciones
CA31447P1009
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 29
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25/04/14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 01/11/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25/08/11 |
Khalid Islam
CHM | Chairman | 67 | 25/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25/04/14 |
Marco Brughera
BRD | Director/Board Member | 70 | 10/08/16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/07/09 |
Jodi Cook
BRD | Director/Board Member | 56 | 24/09/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 322 141 | 22 174 779 ( 81,16 %) | 0 | 81,16 % |
Información de la empresa
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M | |
+77,64 % | 8873,08 M |